Submitted:
17 August 2026
Posted:
19 August 2026
You are already at the latest version
Abstract
Three novel compounds with potential antitubercular activity—N-(2-isonicotinoylhydrazine-1-carbonothioyl)benzamide (3), N-(2-nicotinoylhydrazine-1-carbonothioyl)benzamide (4), and N-(2-picolinoylhydrazine-1-carbonothioyl)benzamide (5) were synthesized in good yields via the reaction of benzoyl isothiocyanate with isonicotinic hydrazide, nicotinic hydrazide, and picolinic hydrazide in acetonitrile, respectively. The crystal structures of compounds (3) and (5) were determined by single-crystal X-ray diffraction analysis; both structures exhibit intramolecular C=O···H-N hydrogen bonds, as well as C=S···H-N interactions. Computational pharmacological studies, ADME profiling, and molecular docking were performed for the three synthesized compounds, indicating that they represent promising candidates as alternatives to current tuberculosis treatment regimens, owing to their predicted favorable pharmacokinetic profile and binding affinity for the Mycobacterium tuberculosis InhA enzyme.
Keywords:
aroyl thioureas
; N-(2-isonicotinoylhydrazine-1-carbonothioyl)benzamide
; N-(2-nicotinoylhydrazine-1-carbonothioyl)benzamide
; N-(2-picolinoylhydrazine-1-carbonothionyl)-benzamide
; crystal structure
; molecular docking
; Mycobacterium tuberculosis
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.